{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:00:31Z","timestamp":1790780431489,"version":"4.1.0"},"reference-count":50,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,1,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hedgehog (HH) signaling is activated in various lymphoid malignancies, but conflicting results exist about its role in chronic lymphocytic leukemia (CLL). Here, we demonstrate that the expression of essential HH pathway components like GLI1, PTCH1, and the HH ligands is highly diverse in CLL. A subset of 36.7% of 60 tested CLL samples responded to all 3 SMOOTHENED (SMO) inhibitors, whereas 40% were completely resistant. Responsiveness correlated with elevated GLI1 and PTCH1 transcript levels and the presence of trisomy 12, whereas no other karyotype correlated with responsiveness. All trisomy 12 CLLs displayed constitutive HH pathway activation driven by autocrine DESERT HH (DHH) ligand secretion, which could be blocked by the HH-blocking Ab 5E1. Cocultures with DHH-expressing BM stromal cells reduced sensitivity of CLLs to SMO-inhibitor treatment by activation of noncanonical ERK phosphorylation directly downstream of the PTCH1 receptor without involvement of SMO and could be overcome by the HH-blocking Ab 5E1 or a combination of SMO and ERK inhibitors. Our results demonstrate that the HH-signaling pathway is an interesting therapeutic target for a subset of patients with CLL, characterized by high GLI1 and PTCH1 transcript levels, and all patients with trisomy 12 and indicate HH-blocking Abs to be favorable over SMO inhibitors in overcoming stroma-mediated protective effects.<\/jats:p>","DOI":"10.1182\/blood-2011-06-359075","type":"journal-article","created":{"date-parts":[[2011,12,2]],"date-time":"2011-12-02T12:26:02Z","timestamp":1322828762000},"page":"997-1007","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":40,"title":["Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL"],"prefix":"10.1182","volume":"119","author":[{"given":"Sarah","family":"Decker","sequence":"first","affiliation":[{"name":"Department of Hematology\/Oncology, University Medical Center Freiburg, Freiburg, Germany;"},{"name":"Faculty of Biology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Zirlik","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Medical Center Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauritte","family":"Djebatchie","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Medical Center Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hartmann","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Medical Center Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Ihorst","sequence":"additional","affiliation":[{"name":"Clinical Trials Unit, Department of Medical Biometry and Statistics and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schmitt-Graeff","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Medical Center Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Herchenbach","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Medical Center Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Jumaa","sequence":"additional","affiliation":[{"name":"Faculty of Biology, University of Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Warmuth","sequence":"additional","affiliation":[{"name":"H3 Biomedicine, Cambridge, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Veelken","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Medical Center Freiburg, Freiburg, Germany;"},{"name":"Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Dierks","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, University Medical Center Freiburg, Freiburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"12","key":"2019111807440197000_B1","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1080\/10428190412331272703","article-title":"Microenvironmental interactions and survival of CLL B-cells.","volume":"45","author":"Munk Pedersen","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2019111807440197000_B2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia.","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"issue":"2","key":"2019111807440197000_B3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.bloodjournal462219","article-title":"Clinical staging of chronic lymphocytic leukemia.","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"issue":"1","key":"2019111807440197000_B4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"issue":"6","key":"2019111807440197000_B5","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"12","key":"2019111807440197000_B6","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"Zap-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.","volume":"101","author":"Wiestner","year":"2003","journal-title":"Blood"},{"issue":"9","key":"2019111807440197000_B7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1056\/NEJMoa040857","article-title":"Zap-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.","volume":"351","author":"Rassenti","year":"2004","journal-title":"N Engl J Med"},{"issue":"26","key":"2019111807440197000_B8","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia.","volume":"343","author":"D\u00f6hner","year":"2000","journal-title":"N Engl J Med"},{"issue":"12","key":"2019111807440197000_B9","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111807440197000_B10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.beha.2009.12.002","article-title":"Therapy of chronic lymphocytic leukaemia.","volume":"23","author":"Hallek","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"issue":"13","key":"2019111807440197000_B11","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1182\/blood-2005-05-1778","article-title":"Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemia.","volume":"106","author":"Gribben","year":"2005","journal-title":"Blood"},{"issue":"1","key":"2019111807440197000_B12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF02934774","article-title":"Environmental factors and leukaemia.","volume":"2","author":"Brandt","year":"1985","journal-title":"Med Oncol Tumor Pharmacother"},{"issue":"5","key":"2019111807440197000_B13","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1182\/blood-2004-12-4918","article-title":"Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells.","volume":"106","author":"Burger","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2019111807440197000_B14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nrclinonc.2009.72","article-title":"Molecular and cellular mechanisms of CLL: novel therapeutic approaches.","volume":"6","author":"Pleyer","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"2019111807440197000_B15","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1.","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"issue":"8","key":"2019111807440197000_B16","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1614","article-title":"Essential role of stromally induced hedgehog signaling in B-cell malignancies.","volume":"13","author":"Dierks","year":"2007","journal-title":"Nat Med"},{"issue":"23","key":"2019111807440197000_B17","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1101\/gad.938601","article-title":"Hedgehog signaling in animal development: paradigms and principles.","volume":"15","author":"Ingham","year":"2001","journal-title":"Genes Dev"},{"issue":"7","key":"2019111807440197000_B18","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1101\/gad.1902910","article-title":"The output of hedgehog signaling is controlled by the dynamic association between suppressor of fused and the Gli proteins.","volume":"24","author":"Humke","year":"2010","journal-title":"Genes Dev"},{"issue":"6886","key":"2019111807440197000_B19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/417299a","article-title":"Hedgehog regulates cell growth and proliferation by inducing cyclin D and cyclin E.","volume":"417","author":"Duman-Scheel","year":"2002","journal-title":"Nature"},{"issue":"36","key":"2019111807440197000_B20","doi-asserted-by":"crossref","first-page":"5529","DOI":"10.1038\/sj.onc.1205748","article-title":"Human GLI2 and GLI1 are part of a positive feedback mechanism in basal cell carcinoma.","volume":"21","author":"Regl","year":"2002","journal-title":"Oncogene"},{"issue":"6","key":"2019111807440197000_B21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/j.0022-202X.2004.22612.x","article-title":"GLI2 is expressed in normal human epidermis and BCC and induces GLI1 expression by binding to its promoter.","volume":"122","author":"Ikram","year":"2004","journal-title":"J Invest Dermatol"},{"issue":"6","key":"2019111807440197000_B22","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0896-6273(00)80645-5","article-title":"Hedgehog and patched in neural development and disease.","volume":"21","author":"Goodrich","year":"1998","journal-title":"Neuron"},{"issue":"5586","key":"2019111807440197000_B23","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1126\/science.1073733","article-title":"Medulloblastoma growth inhibition by hedgehog pathway blockade.","volume":"297","author":"Berman","year":"2002","journal-title":"Science"},{"issue":"5313","key":"2019111807440197000_B24","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1126\/science.276.5313.817","article-title":"Basal cell carcinomas in mice overexpressing sonic hedgehog.","volume":"276","author":"Oro","year":"1997","journal-title":"Science"},{"issue":"6662","key":"2019111807440197000_B25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/34201","article-title":"Activating smoothened mutations in sporadic basal-cell carcinoma.","volume":"391","author":"Xie","year":"1998","journal-title":"Nature"},{"issue":"1","key":"2019111807440197000_B26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/sj.jidsp.5640179","article-title":"Ultraviolet radiation mutagenesis of hedgehog pathway genes in basal cell carcinomas.","volume":"4","author":"Aszterbaum","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"6960","key":"2019111807440197000_B27","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nature01972","article-title":"Widespread requirement for hedgehog ligand stimulation in growth of digestive tract tumours.","volume":"425","author":"Berman","year":"2003","journal-title":"Nature"},{"issue":"7009","key":"2019111807440197000_B28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature02962","article-title":"Hedgehog signalling in prostate regeneration, neoplasia and metastasis.","volume":"431","author":"Karhadkar","year":"2004","journal-title":"Nature"},{"key":"2019111807440197000_B29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1476-4598-3-29","article-title":"Activation of the hedgehog pathway in advanced prostate cancer.","volume":"3","author":"Sheng","year":"2004","journal-title":"Mol Cancer"},{"issue":"6960","key":"2019111807440197000_B30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nature02009","article-title":"Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis.","volume":"425","author":"Thayer","year":"2003","journal-title":"Nature"},{"issue":"5","key":"2019111807440197000_B31","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-06-3281","article-title":"Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.","volume":"67","author":"Feldmann","year":"2007","journal-title":"Cancer Res"},{"issue":"6929","key":"2019111807440197000_B32","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature01493","article-title":"Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer.","volume":"422","author":"Watkins","year":"2003","journal-title":"Nature"},{"issue":"9","key":"2019111807440197000_B33","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.biocel.2010.04.016","article-title":"Activation of Erk by sonic hedgehog independent of canonical hedgehog signalling.","volume":"42","author":"Chang","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"2019111807440197000_B34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ccr.2008.08.003","article-title":"Expansion of Bcr-Abl-positive leukemic stem cells is dependent on hedgehog pathway activation.","volume":"14","author":"Dierks","year":"2008","journal-title":"Cancer Cell"},{"issue":"7239","key":"2019111807440197000_B35","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nature07737","article-title":"Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia.","volume":"458","author":"Zhao","year":"2009","journal-title":"Nature"},{"issue":"6","key":"2019111807440197000_B36","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.stem.2009.03.015","article-title":"Hedgehog signaling is dispensable for adult hematopoietic stem cell function.","volume":"4","author":"Gao","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"6","key":"2019111807440197000_B37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.stem.2009.03.016","article-title":"Hedgehog signaling is dispensable for adult murine hematopoietic stem cell function and hematopoiesis.","volume":"4","author":"Hofmann","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"5","key":"2019111807440197000_B38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/leu.2010.35","article-title":"Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation.","volume":"24","author":"Singh","year":"2010","journal-title":"Leukemia"},{"issue":"6","key":"2019111807440197000_B39","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-08-1808","article-title":"Sonic hedgehog signaling pathway is activated in ALK-positive anaplastic large cell lymphoma.","volume":"69","author":"Singh","year":"2009","journal-title":"Cancer Res"},{"issue":"6","key":"2019111807440197000_B40","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1158\/1535-7163.MCT-07-2118","article-title":"Targeting of sonic hedgehog-gli signaling: a potential strategy to improve therapy for mantle cell lymphoma.","volume":"7","author":"Hegde","year":"2008","journal-title":"Mol Cancer Ther"},{"issue":"10","key":"2019111807440197000_B41","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1073\/pnas.0611682104","article-title":"Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma.","volume":"104","author":"Peacock","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2019111807440197000_B42","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1158\/1541-7786.MCR-08-0142","article-title":"Hedgehog-induced survival of B-cell chronic lymphocytic leukemia cells in a stromal cell microenvironment: a potential new therapeutic target.","volume":"6","author":"Hegde","year":"2008","journal-title":"Mol Cancer Res"},{"issue":"35","key":"2019111807440197000_B43","doi-asserted-by":"crossref","first-page":"4885","DOI":"10.1038\/onc.2010.243","article-title":"Inhibition of GLI, but not smoothened, induces apoptosis in chronic lymphocytic leukemia cells.","volume":"29","author":"Desch","year":"2010","journal-title":"Oncogene"},{"issue":"3","key":"2019111807440197000_B44","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1182\/blood-2006-07-034256","article-title":"Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.","volume":"109","author":"Pfeifer","year":"2007","journal-title":"Blood"},{"issue":"18","key":"2019111807440197000_B45","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1242\/dev.125.18.3553","article-title":"The teratogenic veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction.","volume":"125","author":"Incardona","year":"1998","journal-title":"Development"},{"issue":"6799","key":"2019111807440197000_B46","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/35023008","article-title":"Effects of oncogenic mutations in smoothened and patched can be reversed by cyclopamine.","volume":"406","author":"Taipale","year":"2000","journal-title":"Nature"},{"issue":"51","key":"2019111807440197000_B47","doi-asserted-by":"crossref","first-page":"51ra70","DOI":"10.1126\/scitranslmed.3001599","article-title":"Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma.","volume":"2","author":"Buonamici","year":"2010","journal-title":"Sci Transl Med"},{"issue":"14","key":"2019111807440197000_B48","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1021\/jm900305z","article-title":"Discovery of a potent and orally active hedgehog pathway antagonist (IPI-926).","volume":"52","author":"Tremblay","year":"2009","journal-title":"J Med Chem"},{"issue":"12","key":"2019111807440197000_B49","doi-asserted-by":"crossref","first-page":"e15262","DOI":"10.1371\/journal.pone.0015262","article-title":"Self-renewal of acute lymphocytic leukemia cells is limited by the hedgehog pathway inhibitors cyclopamine and IPI-926.","volume":"5","author":"Lin","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"2019111807440197000_B50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(00)81386-0","article-title":"Two critical periods of sonic hedgehog signaling required for the specification of motor neuron identity.","volume":"87","author":"Ericson","year":"1996","journal-title":"Cell"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/4\/997\/1355154\/zh800412000997.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/4\/997\/1355154\/zh800412000997.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,18]],"date-time":"2021-12-18T10:56:25Z","timestamp":1639824985000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/4\/997\/29713\/Trisomy-12-and-elevated-GLI1-and-PTCH1-transcript"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,26]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,1,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-06-359075","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,26]]}}}